feed,title,long_url,short_url
SeekingAlpha,bluebird bio: Potential For 3 Gene Therapy Approvals In 12 Months Makes Buy Case,https://seekingalpha.com/article/4519724,
SeekingAlpha,Silgan Is A Reasonable Long-Term Buy At Today's Price,https://seekingalpha.com/article/4519723,
SeekingAlpha,More Air Hisses Out Of The Housing Bubble,https://seekingalpha.com/article/4519722,
